Real-world outcomes of rivaroxaban treatment in elderly Japanese patients with nonvalvular atrial fibrillation

Direct oral anticoagulants (DOACs), such as rivaroxaban, reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF). However, it is still unclear whether the stroke reduction benefit outweighs the bleeding risk in elderly Japanese patients with NVAF. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitazono, Takanari, Ikeda, Takanori, Ogawa, Satoshi, Nakagawara, Jyoji, Minematsu, Kazuo, Miyamoto, Susumu, Murakawa, Yuji, Cavaliere, Mary, Hayashi, Yasuhiro, Kidani, Yoko, Okayama, Yutaka, Sunaya, Toshiyuki, Sato, Shoichiro, Yamanaka, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026217/
https://www.ncbi.nlm.nih.gov/pubmed/31492970
http://dx.doi.org/10.1007/s00380-019-01487-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026217/
https://www.ncbi.nlm.nih.gov/pubmed/31492970
http://dx.doi.org/10.1007/s00380-019-01487-x

Ejemplares similares